You are here:

MS in the media - 23 September 2015

Published on

These are links to recent news stories that may be of interest to people in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter.

NICE social care guidelines published

In its first guideline for social care, NICE says carer visits to older or disabled people living at home should be at least 30 minutes and that people should see the same carer(s) and not different ones each time.  It also recommends more training for carers and better coordination with health services.  NICE recognises that meetings these guidelines will cost more.

Source: NICE
Source: BBC
Source: Guardian

New progressive MS research grants

The Progressive MS Alliance has awarded 11 more research grants for studies around the world, including a study of mitochondria at the University of Edinburgh.  In its role in connecting similar projects around the world, a study targeting microglia in progressive MS at Imperial College in London has been matched with a team working in Paris.

Source: National MS Society (USA)

MS Trust link: Progressive MS - A to Z of MS

Disease modifying drugs review

A Cochrane review of disease modifying drugs for relapsing MS found that the best at reducing relapse in the first two years of treatment were alemtuzumab, mitoxantrone, natalizumab and fingolimod.  The best at reducing the build up of disability in the same period were mitoxantrone, alemtuzumab, and natalizumab.  The review criticises the lack of long-term evidence for efficacy and side effects.

Source: MS News Today

MS Trust link: Disease modifying drugs for relapsing MS

What affects quality of life in MS

Czech research into factors that have a negative effect on quality of life for people with MS identified the label of MS, cognitive symptoms, sexual dysfunction and family problems.  The researchers also point out the failings in the scales used to measure quality of life.

Source: MS News Today

MS Trust link: Cognition and cognitive symptoms
MS Trust link: Talking about sexual problems
MS Trust link: Living with progressive MS in the family

Print this page